XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Operating activities              
Net income $ 148.5 $ 154.9 $ 186.1 $ 133.3 $ 303.4 $ 319.4  
Loss from discontinued operations, net of tax         0.0 0.2  
Adjustments to reconcile net income from continuing operations to net cash provided by (used for) operating activities              
Equity income of unconsolidated subsidiaries         (0.4) (1.1)  
Depreciation 14.6   15.5   29.4 30.4  
Amortization 14.3   13.4   28.5 26.9  
Deferred income taxes         18.5 12.6  
Loss on sale of business 26.3   0.0   26.3 0.0  
Share-based compensation 8.6   8.4   21.2 16.3  
Asset impairment and write-offs         47.0 0.8  
Changes in assets and liabilities, net of effects of business acquisitions              
Accounts receivable         33.4 (10.7)  
Inventories         (9.9) 23.5  
Other current assets         (27.3) (4.0)  
Accounts payable         39.4 19.4  
Employee compensation and benefits         (18.9) (19.4)  
Other current liabilities         66.6 6.6  
Other non-current assets and liabilities         10.5 10.9  
Net cash provided by operating activities of continuing operations         567.7 431.8  
Net cash used for operating activities of discontinued operations         0.0 (0.2)  
Net cash provided by operating activities         567.7 431.6  
Investing activities              
Capital expenditures         (27.7) (36.3)  
Purchase of investments         (18.0) 0.0  
Proceeds from sale of property and equipment         0.1 0.0  
Other         0.2 (0.5)  
Net cash used for investing activities         (45.4) (36.8)  
Financing activities              
Net (repayments) receipts of short-term borrowings         (9.2) 3.3  
Net borrowings of revolving long-term debt         9.9 0.0  
Repayments of long-term debt         (250.0) (237.5)  
Debt issuance costs         (2.1) 0.0  
Shares issued to employees, net of shares withheld         (10.6) 9.3  
Repurchases of ordinary shares         (125.0) (50.0)  
Dividends paid         (82.4) (76.2)  
Net cash used for financing activities         (469.4) (351.1)  
Effect of exchange rate changes on cash and cash equivalents         (28.6) 0.3  
Change in cash and cash equivalents         24.3 44.0  
Cash and cash equivalents, beginning of period   $ 118.7   $ 170.3 118.7 170.3 $ 170.3
Cash and cash equivalents, end of period $ 143.0   $ 214.3   $ 143.0 $ 214.3 $ 118.7